These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 8057240
1. [Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study]. Inoue K, Nakamura N, Kakio T, Suyama H, Tanaka S, Goto Y, Nakazawa Y, Yamamoto Y, Nagamatsu T. J Cardiol; 1994; 24(4):279-91. PubMed ID: 8057240 [Abstract] [Full Text] [Related]
2. Restenosis after percutaneous transluminal coronary angioplasty--a histopathological study using autopsied hearts. Morimoto S, Mizuno Y, Hiramitsu S, Yamada K, Kubo N, Nomura M, Yamaguchi T, Kitazume H, Kodama K, Kurogane H. Jpn Circ J; 1990 Jan; 54(1):43-56. PubMed ID: 2332932 [Abstract] [Full Text] [Related]
3. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Ueda M, Becker AE, Kasayuki N, Kojima A, Morita Y, Tanaka S. Am J Pathol; 1996 Sep; 149(3):831-43. PubMed ID: 8780387 [Abstract] [Full Text] [Related]
4. The early phenomena of restenosis following percutaneous transluminal coronary angioplasty. Ueda M, Becker AE, Fujimoto T, Tsukada T. Eur Heart J; 1991 Aug; 12(8):937-45. PubMed ID: 1915432 [Abstract] [Full Text] [Related]
6. Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Ueda M, Becker AE, Naruko T, Kojima A. Coron Artery Dis; 1995 Jan; 6(1):71-81. PubMed ID: 7767506 [Abstract] [Full Text] [Related]
7. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis. Deiner C, Loddenkemper C, Rauch U, Rosenthal P, Pauschinger M, Schwimmbeck PL, Schultheiss HP, Pels K. Cardiovasc Revasc Med; 2007 Jan; 8(2):94-8. PubMed ID: 17574167 [Abstract] [Full Text] [Related]
8. The paradigm of restenosis following percutaneous transluminal coronary angioplasty. Preisack MB, Karsch KR. Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774 [Abstract] [Full Text] [Related]
9. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty. Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTassel JW, Peters T. Circulation; 1991 Feb; 83(2 Suppl):I28-41. PubMed ID: 1991400 [Abstract] [Full Text] [Related]
11. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Circulation; 1991 Apr; 83(4):1327-32. PubMed ID: 2013150 [Abstract] [Full Text] [Related]
12. The natural history of collagen and alpha-actin expression after coronary angioplasty. Schmidt MR, Maeng M, Kristiansen SB, Andersen HR, Falk E. Cardiovasc Pathol; 2004 Apr; 13(5):260-7. PubMed ID: 15358340 [Abstract] [Full Text] [Related]
13. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. Matsuura R, Isaka N, Imanaka-Yoshida K, Yoshida T, Sakakura T, Nakano T. J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811 [Abstract] [Full Text] [Related]
14. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation]. Shimizu N, Suzuki H, Wakabayashi K, Iso Y, Shibata M, Yorozuya M, Katagiri T, Takeyama Y. J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801 [Abstract] [Full Text] [Related]
15. [Mechanisms and prevention of restenosis after coronary angioplasty]. Drechsel S, Bertel O, Lafont A. Schweiz Med Wochenschr; 1998 Mar 28; 128(13):497-507. PubMed ID: 9583101 [Abstract] [Full Text] [Related]
16. [Pathologic changes at the coronary artery-bypass graft anastomosis--an immunocytochemical study]. Sasaki Y, Ueda M, Suehiro S, Kimura E, Nishizawa K, Shibata T, Hattori K, Kinoshita H. Nihon Kyobu Geka Gakkai Zasshi; 1993 Aug 28; 41(8):1307-15. PubMed ID: 8360530 [Abstract] [Full Text] [Related]
17. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M. J Physiol Pharmacol; 2001 Aug 28; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [Abstract] [Full Text] [Related]
18. Effects of recombinant human basic fibroblast growth factor on restenosis after arterial endothelial injury in rats. Chang L, Zhang C, Wu YJ, Zhu RZ. Acta Pharmacol Sin; 2001 Oct 28; 22(10):876-80. PubMed ID: 11749768 [Abstract] [Full Text] [Related]
19. [Morphological and histological studies of in-stent restenosis in seven types of stents implanted in porcine coronary arteries]. Yorozuya M, Takeyama Y, Iso Y, Shibata M, Nakatani M, Koba S, Suzuki H, Murakami M, Katagiri T. J Cardiol; 2001 Nov 28; 38(5):273-80. PubMed ID: 11729727 [Abstract] [Full Text] [Related]
20. [Gene therapy for the treatment of restenosis after coronary angioplasty]. Rapacciuolo A, Indolfi C, Di Lorenzo E, Esposito G, Stabile E, Stingone AM, Avvedimento EV, Condorelli M, Chiariello M. Cardiologia; 1994 Dec 28; 39(12):843-7. PubMed ID: 7781002 [Abstract] [Full Text] [Related] Page: [Next] [New Search]